Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|13|11|1432-1444

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.11, 2012-10, pp. : 1432-1444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds

By  

Medicinal Chemistry, Vol. 6, Iss. 5, 2010-09 ,pp. : 286-297

Bentham Science Publishers

Access to resources Recommend Favorite

The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-08 ,pp. : 837-857

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase II As Novel Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 694-709

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications

By Miyamoto Shuichi  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 621-631

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite